The goal of this clinical trial is to learn if sub-threshold dorsal root ganglion (DRG) stimulation provides pain relief beyond placebo in adults with chronic neuropathic pain who already have an implanted DRG stimulator. The main questions it aims to answer are: * Does sub-threshold DRG stimulation reduce daily pain intensity compared with sham stimulation? * How does sub-threshold stimulation affect sleep, mood, and daily activity? Researchers will compare active sub-threshold DRG stimulation to sham (device switched off) to see if stimulation has a genuine effect on pain and wellbeing. Participants will: * Be randomly assigned to receive either active sub-threshold DRG stimulation or sham stimulation for 5 days, followed by the opposite condition for another 5 days. * Complete short electronic diaries twice daily about their pain, sleep, mood, and activity. * Attend study visits for safety checks and assessments.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Average daily pain intensity (Numeric Rating Scale, 0-10)
Timeframe: Twice daily (morning and evening) from Day 0 through Day 11 (includes both 5-day treatment periods and the two 24-hour washout periods on Day 0 and Day 6).